The Current Ratio as of November 2024 (TTM) for Genenta Science S.p.A. (GNTA) is 12.25

According to Genenta Science S.p.A.’s latest financial reports and current stock price. The company's current Current Ratio is 12.25. This represents a change of -6.10% compared to the average of 13.04 of the last 4 quarters.

Genenta Science S.p.A. (GNTA) Historical Current Ratio (quarterly & annually)

How has GNTA Current Ratio performed in the past?

The mean historical Current Ratio of Genenta Science S.p.A. over the last ten years is 15.26. The current 12.25 Current Ratio has changed 7.93% with respect to the historical average. Over the past ten years (40 quarters), GNTA's Current Ratio was at its highest in in the September 2021 quarter at 34.15. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Genenta Science S.p.A. (GNTA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Genenta Science S.p.A. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Genenta Science S.p.A. (GNTA) Average Current Ratio

How has GNTA Current Ratio performed in the past?

The current Current Ratio of Genenta Science S.p.A. (GNTA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Genenta Science S.p.A. (GNTA) Current Ratio vs. Peers

How is GNTA’s Current Ratio compared to its peers?

Genenta Science S.p.A.’s Current Ratio is less than Molecular Partners AG (14.58), less than MediciNova, Inc. (18.24), less than Anebulo Pharmaceuticals, Inc. (13.46), greater than Champions Oncology, Inc. (0.69), less than Cyteir Therapeutics, Inc. (21.89), less than PMV Pharmaceuticals, Inc. (19.22), less than Eliem Therapeutics, Inc. (60.41), less than Pharvaris N.V. (18.45), greater than PepGen Inc. (7.45), greater than Mineralys Therapeutics, Inc. (11.20), less than Janux Therapeutics, Inc. (57.34), less than Rezolute, Inc. (13.39), less than Opthea Limited (0), greater than Pardes Biosciences, Inc. (2.94), less than AN2 Therapeutics, Inc. (81.72), greater than Aerovate Therapeutics, Inc. (10.61), greater than Adagene Inc. (6.51), greater than null (2.50),

Build a custom stock screener for Genenta Science S.p.A. (GNTA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genenta Science S.p.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genenta Science S.p.A. (GNTA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genenta Science S.p.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.